CGP invests in innovations across the Life Sciences industry.Our target technologies are breakthroughs with unmet clinical need, strong IP protection, and the appeal to become a must-have for strategi
...
Clinical stage company Main asset: anticancer immunotherapy DNA. In Phase I/II human trials conducted ex-US, Elenagen demonstrated a statistically significant extension of progression-free (PFS) and o
...
Cadenza Bio is a biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.
CLS is largest statewide advocacy and business leadership trade association representing the life sciences industry. CLSAsupports over 1,300 corporate member organization focused on the growth of Cali
...
Canary Cure Therapeutics is a late-stage preclinical biotechnology company pioneering a paradigm shift in the treatment of obesity and metabolic diseases. While first-generation therapies have validat
...
)
)
)
)
)
)
